F-star

F-star Biotechnology Ltd. was a biotechnology company, founded in Vienna in 2006,^[1] with a former main research site in Cambridge, UK. The company was focused on developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.^[2][3]